Rebus Biosystems Revenue and Competitors

Location

$20M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Rebus Biosystems's estimated annual revenue is currently $1.3M per year.(i)
  • Rebus Biosystems's estimated revenue per employee is $77,500
  • Rebus Biosystems's total funding is $20M.

Employee Data

  • Rebus Biosystems has 17 Employees.(i)
  • Rebus Biosystems grew their employee count by -15% last year.

Rebus Biosystems's People

NameTitleEmail/Phone
1
Controller - Finance and AccountingReveal Email/Phone
2
VP, ChemistryReveal Email/Phone
3
VP, Commercial Operations, EMEAReveal Email/Phone
4
Director, MarketingReveal Email/Phone
5
Associate Director Assay and SystemsReveal Email/Phone
6
Customer Success Manager at REBUS BiosystemsReveal Email/Phone
7
Office ManagerReveal Email/Phone
8
Manufacturing Engineer & Field Service EngineerReveal Email/Phone
9
Document Control SupervisorReveal Email/Phone
10
Bioinformatics ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Rebus Biosystems?

At Rebus Biosystems, our vision is spatial omics without compromise. Get subcellular resolution of biological molecules directly in and across large tissue sections. Customizable assays allow you to focus on the targets that matter most to your research. Available as a fully automated, integrated instrument for your lab in early 2021. Get access now available through our Spatial Omics as a Service program.

keywords:N/A

$20M

Total Funding

17

Number of Employees

$1.3M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Rebus Biosystems News

2021-03-01 - Rebus Biosystems Launches Automated Spatial Omics Platform

SANTA CLARA, Calif., March 1, 2021 /PRNewswire/ -- Rebus Biosystems, Inc., a life science technology company creating revolutionary tools to enable spatial omics research without compromise, today announced the launch of the Rebus Esper™ spatial omics platform. The new spatial omics platform w ...

2020-11-19 - Rebus Biosystems, Inc. Announces $20 Million Series B Financing to Support Commercialization of Automated Spatial Omics Solution

SANTA CLARA, Calif., Nov. 19, 2020 /PRNewswire/ -- Rebus Biosystems, Inc., a life science technology company building innovative tools to enable spatial omics without compromise, today announced the closing of a $20 million Series B financing round, led by Illumina Ventures and joined by Lifec ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M176%N/A
#2
$3.1M17N/AN/A
#3
$1.5M17-6%N/A
#4
$0.6M17-15%$74M
#5
$2.6M17-11%N/A